Articles

Studies with Zenith-CKD showed significant albuminuria reduction.

AstraZeneca Reports Positive Results Phase IIb Chronic Kidney Disease Trial

Boehringer Ingelheim Delivers Promising Results in Phase II Chronic Kidney Disease Trial

There are a slew of specialist and boutique companies set up to provide high quality services and to meet the changing needs of the pharma industry.

Creating Strategic Relationships: The Changing Face of Contract Research Organizations and Sponsor Partnerships

Head of Global Commercial Innovation at Genmab

While there are still hurdles to overcome along the way, home healthcare could deliver better patient-centered cancer care, providing improved patient outcomes, enhanced quality of life, and reduced strain on resources.

The Future State of Oncology: The Rise of Oncology Home Care

With new tech acquisition, the software company also introduces a new branded AI assistant for mobile devices specifically for the life sciences sector.

Aktana Attains Tact.ai’s Field Engagement and Conversational AI Technology

Study describes how biotech startups can avoid competing with large pharma companies for financing. 

Report Explores Ways to Finance, Repurpose Rare Disease Drugs

R&D teams need to accelerate how they conduct their research, get to a material, and get to market. 

Key Challenges in Research and Development of Chemicals and Materials 

The newly approved Alinity m high risk human papillomavirus (HPV) assay is indicated to detect HPV and for use in routine cervical cancer screening per professional medical guidelines.

FDA Approves Abbott's HPV Test to Run on Alinity M Assay Platform

Determination will affect future vaccine cost and accessibility, including in developing countries.

Analysis Shows BRICS Nations Are Making Strides in Vaccine Production

Phathom Pharmaceuticals announced that it anticipates vonoprazan (Voquenza) to be commercially available by December 2023.

News